Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues.

Benjamin Clubbs Coldron, Vivien Coates, Amjed Khamis, Sandra MacRury
Author Information
  1. Benjamin Clubbs Coldron: Division of Rural Health and Wellbeing, Centre for Health Science, University of Highlands and Islands, Inverness, UK. ORCID
  2. Vivien Coates: School of Nursing, Ulster University, Derry, UK.
  3. Amjed Khamis: Letterkenny University Hospital, Letterkenny, Ireland.
  4. Sandra MacRury: Division of Rural Health and Wellbeing, Centre for Health Science, University of Highlands and Islands, Inverness, UK.

Abstract

BACKGROUND: Evidence indicates that poor glycemic control is associated with increased morbidity and length of stay in hospital. There are a wide range of guidelines published, which seek to ensure safe and effective inpatient glycemic control in the hospital setting. However, the implementation of these protocols is limited in practice. In particular, the feasibility of "flash" and continuous glucose monitoring (CGM) remains untested on general wards.
METHOD: Scoping Review.
RESULTS: If used in the general ward hospital settings, CGM and flash glucose monitoring (FGM) systems could lead to improved glycemic control, decreased length of stay, and reduced risk of severe hypoglycemia or hyperglycemia. Potential problems include lack of experience with this technology and costs of sensors. Rapid analysis of glucose measurements can facilitate clinical decision making and therapy adjustment in the hospital setting. In addition, People with diabetes may be empowered to better self-manage their condition in hospital as they have direct access to their glucose data.
CONCLUSIONS: More studies are required in which the feasibility, benefits and limitations of FGM and CGM in non-intensive care unit hospital settings are elucidated. We need evidence on which types of hospital wards might benefit from the introduction of this technology and the contexts in which they are less useful. We also need to identify the types of People who are most likely to find FGM and CGM useful for self-management and for which populations they have the most benefit in terms of clinical outcomes and length of stay.

Keywords

References

  1. Nutrients. 2018 Jul 29;10(8): [PMID: 30060632]
  2. Diabetes Technol Ther. 2013 Mar;15(3):241-5 [PMID: 23360391]
  3. Diabetes Technol Ther. 2021 Jan;23(1):78-80 [PMID: 32639844]
  4. J Diabetes Sci Technol. 2019 Jul;13(4):674-681 [PMID: 30636449]
  5. J Diabetes Sci Technol. 2017 Sep;11(5):1028-1035 [PMID: 28290224]
  6. BMC Med Res Methodol. 2018 Nov 19;18(1):143 [PMID: 30453902]
  7. Diabet Med. 2018 Apr;35(4):483-490 [PMID: 29230878]
  8. J Diabetes Sci Technol. 2015 Aug 31;10(2):325-9 [PMID: 26330394]
  9. J Clin Transl Endocrinol. 2021 Jul 07;25:100262 [PMID: 34336598]
  10. Diabetes Ther. 2017 Jun;8(3):573-586 [PMID: 28401454]
  11. Diabetes Care. 2020 Nov;43(11):2736-2743 [PMID: 32759361]
  12. Diabetes Care. 2020 Nov;43(11):2730-2735 [PMID: 32641372]
  13. Contact Dermatitis. 2020 Aug;83(2):154-157 [PMID: 32352577]
  14. Diabetes Care. 2021 Feb;44(2):578-585 [PMID: 33323475]
  15. J Diabetes Sci Technol. 2020 Nov;14(6):1035-1064 [PMID: 32985262]
  16. Lancet. 2016 Nov 5;388(10057):2254-2263 [PMID: 27634581]
  17. J Diabetes Sci Technol. 2017 Jul;11(4):766-772 [PMID: 28322063]
  18. Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S3-S13 [PMID: 26784127]
  19. J Diabetes Sci Technol. 2017 Sep;11(5):1036-1044 [PMID: 28429611]
  20. Diabet Med. 2018 Apr;35(4):409-418 [PMID: 29247556]
  21. Clin Diabetes. 2018 Apr;36(2):203-204 [PMID: 29686463]
  22. Diabetes Technol Ther. 2015 Sep;17(9):611-8 [PMID: 25927357]
  23. Diabet Med. 2018 Apr;35(4):472-482 [PMID: 29356072]
  24. Diabetes Ther. 2019 Aug;10(4):1239-1248 [PMID: 31066017]
  25. J Diabetes Sci Technol. 2012 Jul 01;6(4):884-91 [PMID: 22920815]
  26. Diabetes Obes Metab. 2020 Sep;22(9):1678-1682 [PMID: 32533624]
  27. Diabetol Metab Syndr. 2020 Mar 16;12:22 [PMID: 32190124]
  28. Diabetes Care. 2019 Jul;42(7):1178-1184 [PMID: 31036546]
  29. J Diabetes Sci Technol. 2017 Mar;11(2):440-441 [PMID: 27543272]
  30. Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:73-8 [PMID: 23280870]
  31. J Diabetes Sci Technol. 2020 Nov;14(6):1135-1136 [PMID: 32476459]
  32. J Diabetes Sci Technol. 2018 Jan;12(1):20-25 [PMID: 29237288]
  33. Diabetes Care. 2020 Nov;43(11):2873-2877 [PMID: 32855160]
  34. Diabetes Care. 2020 Nov;43(11):e168-e169 [PMID: 32393587]
  35. J Diabetes Investig. 2020 Nov;11(6):1570-1574 [PMID: 32356596]
  36. Diabet Med. 2018 Apr;35(4):460-471 [PMID: 29266376]

MeSH Term

Humans
Blood Glucose Self-Monitoring
Blood Glucose
Diabetes Mellitus
Hyperglycemia
Hospitals

Chemicals

Blood Glucose

Word Cloud

Created with Highcharts 10.0.0hospitalglucosemonitoringCGMglycemiccontrollengthstayFGMinpatientsettingfeasibilitycontinuousgeneralwardsScopingReviewsettingsflashtechnologyclinicalpeoplediabetescareneedtypesbenefitusefulBACKGROUND:EvidenceindicatespoorassociatedincreasedmorbiditywiderangeguidelinespublishedseekensuresafeeffectiveHoweverimplementationprotocolslimitedpracticeparticular"flash"remainsuntestedMETHOD:RESULTS:usedwardsystemsleadimproveddecreasedreducedriskseverehypoglycemiahyperglycemiaPotentialproblemsincludelackexperiencecostssensorsRapidanalysismeasurementscanfacilitatedecisionmakingtherapyadjustmentadditionmayempoweredbetterself-manageconditiondirectaccessdataCONCLUSIONS:studiesrequiredbenefitslimitationsnon-intensiveunitelucidatedevidencemightintroductioncontextslessalsoidentifylikelyfindself-managementpopulationstermsoutcomesUseContinuousGlucoseMonitoringNon-ICUHospitalSettingsPeopleDiabetes:EmergingBenefitsIssuesmellitus

Similar Articles

Cited By